Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 4Prostatic Neoplasms 2Lymphoma, Follicular 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Laryngeal Neoplasms 1Gliosarcoma 1Glioblastoma 1Disease 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Cisplatin 20Cetuximab 11Carboplatin 9Specimen Handling 8Radiotherapy 8Docetaxel 8Radiotherapy, Intensity-Modulated 7Magnetic Resonance Spectroscopy 71,2-diaminocyclohexaneplatinum II citrate 7Platinum 6Fluorouracil 6pembrolizumab 5Radiation 5toripalimab 4Paclitaxel 4cemiplimab 3X-Rays 3Surgical Procedures, Operative 3Celecoxib 3Biopsy 3130-nm albumin-bound paclitaxel 3Taxes 2Standard of Care 2Radiotherapy, Image-Guided 2Hydroxyurea 2Drug Therapy 2tislelizumab 1sodium thiosulfate 1sargramostim 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Laryngeal Neoplasms × gossypol acetic acid × Clear all
NCT01633541 2023-07-20

Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer

University of Michigan Rogel Cancer Center

Phase 2 Completed
55 enrolled 15 charts
Head & Neck

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡